12:00 AM
 | 
Mar 09, 2009
 |  BC Week In Review  |  Company News  |  Other News

Daiichi Sankyo, Eli Lilly cardiovascular news

Reps. Henry Waxman (D-Calif.) and Bart Stupak (D-Mich.) sent letters to Lilly and FDA requesting information about the removal of Dr. Sanjay Kaul from the February FDA panel meeting for Effient prasugrel from Lilly and Daiichi. In the letters, the Reps. said FDA...

Read the full 203 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >